These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7562441)

  • 1. Stereoselective hydrolysis and penetration of propranolol prodrugs: in vitro evaluation using hairless mouse skin.
    Ahmed S; Imai T; Otagiri M
    J Pharm Sci; 1995 Jul; 84(7):877-83. PubMed ID: 7562441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation.
    Ahmed S; Imai T; Otagiri M
    Pharm Res; 1996 Oct; 13(10):1524-9. PubMed ID: 8899845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration.
    Shameem M; Imai T; Yoshigae Y; Sparreboom A; Otagiri M
    J Pharm Sci; 1994 Dec; 83(12):1754-7. PubMed ID: 7891307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma.
    Ahmed S; Imai T; Yoshigae Y; Otagiri M
    Life Sci; 1997; 61(19):1879-87. PubMed ID: 9364192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver.
    Yoshigae Y; Imai T; Horita A; Otagiri M
    Chirality; 1997; 9(7):661-6. PubMed ID: 9366026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug.
    Ahmed S; Imai T; Otagiri M
    Enantiomer; 1997; 2(3-4):181-91. PubMed ID: 9676267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs.
    Udata C; Tirucherai G; Mitra AK
    J Pharm Sci; 1999 May; 88(5):544-50. PubMed ID: 10229647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the ester moiety on stereoselective hydrolysis of several propranolol prodrugs in rat tissues.
    Takahashi K; Tamagawa S; Sakano H; Katagi T; Mizuno N
    Biol Pharm Bull; 1995 Oct; 18(10):1401-4. PubMed ID: 8593445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective hydrolysis of O-acetyl propranolol as prodrug in rat tissue homogenates.
    Takahashi K; Tamagawa S; Haginaka J; Yasuda H; Katagi T; Mizuno N
    J Pharm Sci; 1992 Mar; 81(3):226-7. PubMed ID: 1640358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in-vitro and in-vivo correlative approach to the evaluation of ester prodrugs to improve oral delivery of propranolol.
    Shameem M; Imai T; Otagiri M
    J Pharm Pharmacol; 1993 Apr; 45(4):246-52. PubMed ID: 8098362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of esterases involved in the stereoselective hydrolysis of ester-type prodrugs of propranolol in rat liver and plasma.
    Yoshigae Y; Imai T; Taketani M; Otagiri M
    Chirality; 1999; 11(1):10-3. PubMed ID: 9914648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Aso T; Otagiri M
    Life Sci; 1998; 62(14):1231-41. PubMed ID: 9570338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in stereoselective hydrolase activity in intestinal mucosa.
    Yoshigae Y; Imai T; Horita A; Matsukane H; Otagiri M
    Pharm Res; 1998 Apr; 15(4):626-31. PubMed ID: 9587961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective hydrolysis of O-acetyl propranolol as prodrug in human serum.
    Takahashi K; Haginaka J; Tamagawa S; Nishihata T; Yasuda H; Katagi T
    J Pharm Pharmacol; 1990 May; 42(5):356-7. PubMed ID: 1976786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic inactivation of 2-oxiranylmethyl 2-ethyl-2,5-dimethylhexanoate (C10GE) in skin, lung and liver of human, rat and mouse.
    Boogaard PJ; van Elburg PA; de Kloe KP; Watson WP; van Sittert NJ
    Xenobiotica; 1999 Oct; 29(10):987-1006. PubMed ID: 10574681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of acyclovir prodrug penetration and metabolism through rat skin using a diffusion/bioconversion model.
    Bando H; Sahashi M; Yamashita F; Takakura Y; Hashida M
    Pharm Res; 1997 Jan; 14(1):56-62. PubMed ID: 9034221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous transport and metabolism of nicotinic acid derivatives in hairless mouse skin.
    Rittirod T; Hatanaka T; Kagami N; Katayama K; Koizumi T
    Biol Pharm Bull; 1999 Mar; 22(3):305-9. PubMed ID: 10220289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ester promoieties on transdermal delivery of ketorolac.
    Liu KS; Hsieh PW; Aljuffali IA; Lin YK; Chang SH; Wang JJ; Fang JY
    J Pharm Sci; 2014 Mar; 103(3):974-86. PubMed ID: 24481782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of prednisolone 21-acetate in hairless mouse skin.
    Hikima T; Ohno Y; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 2001; 14(4):203-9. PubMed ID: 11464102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective disposition of flurbiprofen from a mutual prodrug with a histamine H2-antagonist to reduce gastrointestinal lesions in the rat.
    Fukuhara A; Imai T; Otagiri M
    Chirality; 1996; 8(7):494-502. PubMed ID: 8970747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.